Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Huangsens Biotechnology is a life sciences company based in Hangzhou, China, specializing in the development and distribution of biochemical reagents and diagnostic tools. Founded in 2016, the company provides a range of products including ELISA kits, antibodies, and recombinant proteins to support academic and clinical research. Its business model focuses on technical services and the supply of high-quality laboratory consumables to the biotechnology industry. While the company is active in the R&D service sector, it does not maintain a therapeutic drug pipeline. Hangzhou Huangsens Biotechnology serves as a participant in the local Hangzhou high-tech industrial ecosystem, catering primarily to the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Huangsens Biotechnology.